Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2051170rdf:typepubmed:Citationlld:pubmed
pubmed-article:2051170lifeskim:mentionsumls-concept:C0025914lld:lifeskim
pubmed-article:2051170lifeskim:mentionsumls-concept:C0026809lld:lifeskim
pubmed-article:2051170lifeskim:mentionsumls-concept:C0006104lld:lifeskim
pubmed-article:2051170lifeskim:mentionsumls-concept:C0000097lld:lifeskim
pubmed-article:2051170lifeskim:mentionsumls-concept:C0001480lld:lifeskim
pubmed-article:2051170lifeskim:mentionsumls-concept:C1314792lld:lifeskim
pubmed-article:2051170lifeskim:mentionsumls-concept:C0439831lld:lifeskim
pubmed-article:2051170lifeskim:mentionsumls-concept:C1517945lld:lifeskim
pubmed-article:2051170pubmed:issue1lld:pubmed
pubmed-article:2051170pubmed:dateCreated1991-7-23lld:pubmed
pubmed-article:2051170pubmed:abstractTextThe effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on ATP levels in different areas of mouse brain were studied after rapid fixation of cerebral tissue in situ by microwave irradiation. ATP levels in the striatum, ventral mesencephalon, and cerebellum of untreated C57BL/6 mice killed by microwave irradiation were 2-3 times greater than values measured in the brains of animals killed by cervical dislocation. In microwaved mice, administration of MPTP (40 mg/kg s.c.) caused a 10-20% decrease in ATP concentrations as compared to control animals injected with saline. This decrease was relatively rapid and selective because it occurred in both the striatum and ventral mesencephalon, but not in the cerebellar and frontal cortex, at 30, 60, 120, and 240 min after MPTP exposure. Furthermore, ATP loss in the striatum was prevented by mazindol, a catecholamine uptake blocker, indicating a rather selective effect of MPTP on the ATP content of dopaminergic terminals. Results of this study are consistent with mitochondrial damage in the MPTP model of parkinsonism and provide the first direct experimental evidence in vivo that a decrease in ATP may play a role in MPTP-induced neurotoxicity.lld:pubmed
pubmed-article:2051170pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2051170pubmed:languageenglld:pubmed
pubmed-article:2051170pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2051170pubmed:citationSubsetIMlld:pubmed
pubmed-article:2051170pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2051170pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2051170pubmed:statusMEDLINElld:pubmed
pubmed-article:2051170pubmed:monthJullld:pubmed
pubmed-article:2051170pubmed:issn0022-3042lld:pubmed
pubmed-article:2051170pubmed:authorpubmed-author:ChanPPlld:pubmed
pubmed-article:2051170pubmed:authorpubmed-author:LangstonJ WJWlld:pubmed
pubmed-article:2051170pubmed:authorpubmed-author:Di MonteDDlld:pubmed
pubmed-article:2051170pubmed:authorpubmed-author:DeLanneyL ELElld:pubmed
pubmed-article:2051170pubmed:authorpubmed-author:IrwinIIlld:pubmed
pubmed-article:2051170pubmed:issnTypePrintlld:pubmed
pubmed-article:2051170pubmed:volume57lld:pubmed
pubmed-article:2051170pubmed:ownerNLMlld:pubmed
pubmed-article:2051170pubmed:authorsCompleteYlld:pubmed
pubmed-article:2051170pubmed:pagination348-51lld:pubmed
pubmed-article:2051170pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:2051170pubmed:meshHeadingpubmed-meshheading:2051170-...lld:pubmed
pubmed-article:2051170pubmed:meshHeadingpubmed-meshheading:2051170-...lld:pubmed
pubmed-article:2051170pubmed:meshHeadingpubmed-meshheading:2051170-...lld:pubmed
pubmed-article:2051170pubmed:meshHeadingpubmed-meshheading:2051170-...lld:pubmed
pubmed-article:2051170pubmed:meshHeadingpubmed-meshheading:2051170-...lld:pubmed
pubmed-article:2051170pubmed:meshHeadingpubmed-meshheading:2051170-...lld:pubmed
pubmed-article:2051170pubmed:meshHeadingpubmed-meshheading:2051170-...lld:pubmed
pubmed-article:2051170pubmed:meshHeadingpubmed-meshheading:2051170-...lld:pubmed
pubmed-article:2051170pubmed:meshHeadingpubmed-meshheading:2051170-...lld:pubmed
pubmed-article:2051170pubmed:meshHeadingpubmed-meshheading:2051170-...lld:pubmed
pubmed-article:2051170pubmed:year1991lld:pubmed
pubmed-article:2051170pubmed:articleTitleRapid ATP loss caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mouse brain.lld:pubmed
pubmed-article:2051170pubmed:affiliationCalifornia Institute for Medical Research, San Jose 95128.lld:pubmed
pubmed-article:2051170pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2051170pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:2051170pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2051170lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2051170lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2051170lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2051170lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2051170lld:pubmed